Horvat to lead commercial at PharmaEssentia

PharmaEssentia Corp. (TPEx:6446) hired Joseph Horvat as global chief commercial officer. Horvat was general manager at the U.S. subsidiary of MorphoSys AG.

Australia’s  Walter and Eliza Hall Institute of Medical Research (WEHI) named Marnie Blewitt, James Murphy, Tony Papenfuss and Andrew Roberts deputy directors, all effective in January. Blewitt will be responsible for the institute’s structural biology, genetics and gene regulation, and ubiquitin signaling divisions; Murphy for immunology, infection and global health, and inflammation; Papenfuss for advanced technology and biology, bioinformatics/computational biology, and new medicines and diagnostics; and Roberts for ACRF cancer biology, blood cancer and personalized oncology...